Skip Content
You are currently on the new version of our website. Access the old version .

Vaccines, Volume 14, Issue 1

2026 January - 109 articles

Cover Story: Killed whole-cell genome-reduced bacteria (KWC/GRB), a new, rapid, inexpensive, easily manufactured, distribution-friendly, and modular vaccine platform, enables production of vaccine candidates within three weeks. Its modular design supports rapid design–build–test cycles, facilitating the generation of modified antigens with enhanced immunogenicity. Using the platform’s features, we developed strategies to enhance a test antigen’s immunogenicity by nearly an order of magnitude  through the inclusion of immunomodulators and multimeric antigens separated by long alpha-helical linkers in the expressed immunogen. The immunogen-engineering strategies we developed may prove valuable for enhancing responses to low-immunogenicity antigens within the KWC/GRB vaccine platform and beyond, while also contributing to a broader understanding of the determinants of immunogenicity. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (109)

  • Article
  • Open Access
194 Views
13 Pages

22 January 2026

Background: Vibrio harveyi is a major bacterial pathogen threatening turbot aquaculture, necessitating the development of more effective vaccines. Bacterial ghosts (BGs), which are empty bacterial envelopes with preserved surface antigens, offer a pr...

  • Review
  • Open Access
347 Views
11 Pages

22 January 2026

Annual influenza vaccination remains critical for mitigating severe illness and reducing healthcare strain, particularly among high-risk populations. Despite advancements in vaccine platforms, the comparative efficacy of novel vaccines—such as...

  • Article
  • Open Access
360 Views
15 Pages

Development of an mRNA Vaccine for Tick-Borne Encephalitis: Selection of a Prototype Virus Strain

  • Maria A. Nikiforova,
  • Vladimir A. Gushchin,
  • Denis A. Kleymenov,
  • Anastasia M. Kocherzhenko,
  • Evgeniia N. Bykonia,
  • Elena P. Mazunina,
  • Sofia R. Kozlova,
  • Leonid I. Russu,
  • Nadezhda A. Kuznetsova and
  • Alexander L. Gintsburg
  • + 10 authors

21 January 2026

Background/Objectives: While tick-borne encephalitis virus (TBEV) is genetically relatively conserved, the significant antigenic divergence between its main circulating subtypes hinders the development of broadly effective antiviral treatments and va...

  • Article
  • Open Access
259 Views
15 Pages

Preparation and Efficacy Evaluation of Heat-Resistant Freeze-Dried Live-Attenuated Vaccine Formulation of Micropterus salmoides Rhabdovirus

  • Hongru Liang,
  • Guangwei Hu,
  • Xia Luo,
  • Qiang Lin,
  • Xiaozhe Fu,
  • Yinjie Niu,
  • Baofu Ma,
  • Wenwen Xiao,
  • Zhengwei Cui and
  • Ningqiu Li

21 January 2026

Background/Objectives: An attenuated strain of Micropterus salmoides rhabdovirus (MSRV) 0509 with good immunogenicity has been isolated, showing potential as a candidate for live vaccine development. Methods: To improve the shelf life of attenuated s...

  • Review
  • Open Access
353 Views
18 Pages

21 January 2026

Global cancer incidence reached 20 million new cases across 185 countries in 2022, with approximately 10 million cancer-related deaths annually. Among adults with solid tumors and hematological malignancies, infections are a major contributor to morb...

  • Review
  • Open Access
450 Views
29 Pages

Hidden Targets in Cancer Immunotherapy: The Potential of “Dark Matter” Neoantigens

  • Francois Xavier Rwandamuriye,
  • Alec J. Redwood,
  • Jenette Creaney and
  • Bruce W. S. Robinson

21 January 2026

The development of cancer immunotherapies has transformed cancer treatment paradigms, yet durable and tumour-specific responses remain elusive for many patients. Neoantigens, immunogenic peptides arising from tumour-specific genomic alterations, have...

  • Article
  • Open Access
356 Views
17 Pages

21 January 2026

Background/Objectives: While new vaccines are in development; one strategy to increase influenza vaccine coverage is to repurpose current influenza vaccines for intranasal delivery. Methods: To address this goal; mice were vaccinated intranasally wit...

  • Article
  • Open Access
362 Views
12 Pages

Real-World Effectiveness of Seasonal Influenza Vaccines During the 2024–2025 Season: Subgroup Analyses by Virus Subtype, Time Since Vaccination, and Diagnostic Method

  • Yu Jung Choi,
  • Jungmin Lee,
  • Joon Young Song,
  • Seong-Heon Wie,
  • Jacob Lee,
  • Jin-Soo Lee,
  • Hye Won Jeong,
  • Joong Sik Eom,
  • Jang Wook Sohn and
  • Hee Jin Cheong
  • + 6 authors

21 January 2026

Background/Objectives: Despite high vaccination coverage, influenza remains a public health concern in South Korea, particularly in older adults. Continuous evaluation of vaccine effectiveness (VE) is essential to optimize immunization strategies. Me...

  • Article
  • Open Access
284 Views
18 Pages

HPV and HIV Among Youth: Exploring the Role of Knowledge, Risk Perception, and Attitude to Vaccination in Prevention Strategies

  • Silvia Cocchio,
  • Andrea Cozza,
  • Matilde Obici,
  • Elisabetta Conte,
  • Claudia Cozzolino Cangiano,
  • Nicoletta Parise,
  • Patrizia Furlan and
  • Vincenzo Baldo

21 January 2026

Background: Sexually transmitted infections (STIs) represent a significant public health problem due to their impact. Knowledge about them, perceptions of the risk of contracting them, and adherence to prevention strategies such as HPV vaccination ar...

  • Article
  • Open Access
374 Views
12 Pages

Epidemiological Characteristics of Mumps Under Different Immunization Strategies in Henan Province

  • Zhanpei Xiao,
  • Mingxia Lu,
  • Yating Ma,
  • Yan Wang,
  • Mingyu Zhang,
  • Binghui Du,
  • Yiran Bai,
  • Yuzhu Ma and
  • Yanyang Zhang

20 January 2026

Background: On 1 January 2019, a 2-dose mumps-containing vaccine (MuCV) immunization strategy was adopted in Henan Province before the national Expanded Program on Immunization (EPI). This study examines the epidemiological characteristics of mumps c...

  • Article
  • Open Access
278 Views
11 Pages

The Role of MASP1, MASP2, and Mannose-Binding Lectin in the Immune Response to Hepatitis B Vaccination in Infants

  • Ayşe Esra Tapcı,
  • İsmail Bulut,
  • Serçin Taşar,
  • Zeynep Kallimci,
  • Kezban Çavdar Yetkin,
  • Meliha Sevim,
  • Oğuzhan Serin,
  • Medine Ayşin Taşar,
  • Mehmet Şenes and
  • Bülent Alioğlu

20 January 2026

Background: Hepatitis B vaccination is the most effective strategy for preventing chronic hepatitis B virus (HBV) infection; however, interindividual variability in vaccine-induced antibody responses remains a significant challenge in the field. Inna...

  • Article
  • Open Access
305 Views
25 Pages

20 January 2026

Background/Objectives: Respiratory Syncytial Virus (RSV) causes severe disease in infants, the elderly, and immunocompromised individuals, with reinfections linked to poor induction of durable mucosal immunoglobulin A (IgA). We investigated the role...

  • Article
  • Open Access
277 Views
16 Pages

Trusted Sources of COVID-19 Vaccine Information by County Characteristics in North Carolina

  • Bryson T. Staley,
  • Michael E. DeWitt,
  • Jennifer J. Wenner,
  • John W. Sanders,
  • Thomas F. Wierzba and
  • Katherine Poehling

20 January 2026

Background/Objectives: The COVID-19 pandemic disproportionately impacted rural areas across the United States, including rural North Carolina (NC). Consistent with national patterns, COVID-19 vaccination coverage as of December 2022 was higher for no...

  • Correction
  • Open Access
217 Views
1 Page

20 January 2026

There was an error in the original publication [...]

  • Article
  • Open Access
288 Views
17 Pages

Liver Safety Assessment of an Indonesian Hexavalent Vaccine Candidate Through Histopathology and ALT/AST Evaluation in Rats and Rabbits

  • Elisa D. Pratiwi,
  • Tiza W. Mawaddah,
  • Arif R. Sadjuri,
  • Dimas T. Nugroho,
  • Arip Hidayat,
  • Astria N. Nidom,
  • Zakiyyan I. Ayyuba,
  • Eka S. Wahyuningsih,
  • Kuncoro P. Santoso and
  • Chairul A. Nidom
  • + 5 authors

19 January 2026

Background: Administering several separate childhood vaccines can reduce adherence to immunization schedules due to missed appointments and the burden of repeated injections. A hexavalent formulation targeting diphtheria, tetanus, pertussis, hepatiti...

  • Article
  • Open Access
401 Views
24 Pages

A Pool of Ferritin Nanoparticles Delivering Six Proteins of African Swine Fever Virus Induces Robust Humoral and Cellular Immune Responses in Pigs

  • Zhanhao Lu,
  • Dailang Zhong,
  • Xin Song,
  • Jing Lan,
  • Yanjin Wang,
  • Rui Luo,
  • Shengmei Chen,
  • Ruojia Huang,
  • Hua-Ji Qiu and
  • Yuan Sun
  • + 2 authors

19 January 2026

Background/Objectives: Inadequate characterization of protective antigens poses a significant challenge to the development of vaccines for African swine fever (ASF), particularly for antigen-dependent formulations such as subunit, mRNA, and recombina...

  • Article
  • Open Access
567 Views
18 Pages

HPV Vaccination Completion Among Men Who Have Sex with Men Using HIV Pre-Exposure Prophylaxis in Brazil: A Cross-Sectional Study

  • Alvaro Francisco Lopes de Sousa,
  • Lariane Angel Cepas,
  • Isadora Silva de Carvalho,
  • Caíque Jordan Nunes Ribeiro,
  • Guilherme Reis de Santana Santos,
  • Jean Carlos Soares da Silva,
  • Talia Gomes Luz,
  • Ruan Nilton Rodrigues Melo,
  • Lucas Brandão dos Santos and
  • Ana Paula Morais Fernandes
  • + 3 authors

18 January 2026

Background: Men who have sex with men (MSM) using HIV pre-exposure prophylaxis (PrEP) experience a high burden of human papillomavirus (HPV) infection and related diseases, yet data on HPV vaccination among this group in Brazil remain limited. Aims:...

  • Article
  • Open Access
381 Views
16 Pages

Cost-Effectiveness Analysis of a Bivalent Vaccine for Hand, Foot, and Mouth Disease: A Simulation-Based Study in Beijing, China

  • Mengyao Li,
  • Ying Shen,
  • Yonghong Liu,
  • Hui Yao,
  • Zhuowei Luo,
  • Da Huo,
  • Xiang Xu,
  • Wenhui Zhu,
  • Shuaibing Dong and
  • Xiaoli Wang
  • + 3 authors

17 January 2026

Background: Hand, foot, and mouth disease (HFMD) remains a major public-health concern in China. While the monovalent EV-A71 vaccine has effectively reduced EV-A71–associated cases, it offers no protection against CV-A16. The introduction of a...

  • Article
  • Open Access
327 Views
13 Pages

16 January 2026

Background: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality in the elderly. While pneumococcal vaccination is a core preventive measure, it remains unclear whether its association with severe CAP is uniform across all...

  • Article
  • Open Access
568 Views
22 Pages

Extending ImmunoSpot® Assays’ Sensitivity for Detecting Rare Antigen-Specific B Cells to One in a Million—And Possibly Lower

  • Greg A. Kirchenbaum,
  • Noémi Becza,
  • Lingling Yao,
  • Alexey Y. Karulin and
  • Paul V. Lehmann

15 January 2026

Background/Objectives: Despite clonal expansion during a primary immune response, or after subsequent antigen encounters, the frequency of memory B cells (Bmem) specific for an antigen remains low, making their detection difficult. However, unlike se...

  • Article
  • Open Access
336 Views
12 Pages

Protection Against Salmonella by Vaccination with Toxin–Antitoxin Self-Destructive Bacteria

  • Nady Gruzdev,
  • Jacob Pitcovski,
  • Chen Katz,
  • Nili Ruimi,
  • Dalia Eliahu,
  • Caroline Noach,
  • Ella Rosenzweig,
  • Avner Finger and
  • Ehud Shahar

15 January 2026

Background: Salmonella is a major zoonotic foodborne pathogen. Conventional poultry vaccines may present limitations in terms of efficacy, safety, and practicality. Objectives: This study focuses on enhancing the immunogenicity and improving the safe...

  • Article
  • Open Access
374 Views
19 Pages

15 January 2026

Background/objectives: RSV is a major cause of mortality in infants, and despite recent progress to prevent RSV in the very young, an RSV vaccine for this population is still highly warranted. Clinical studies in infants in the 1960s using formalin-i...

  • Article
  • Open Access
384 Views
8 Pages

Family Decision to Immunize Against Respiratory Syncytial Virus and Associations with Seasonal Influenza and COVID-19 Vaccination

  • Leah D. Kaye,
  • Benjamin N. Fogel,
  • Ruth E. Gardner,
  • Brody J. Lipsett,
  • Katherine E. Shedlock,
  • Eric W. Schaefer,
  • Ian M. Paul and
  • Steven D. Hicks

14 January 2026

Background: Nirsevimab, a monoclonal antibody for respiratory syncytial virus (RSV), reduces medically attended RSV infections. It was introduced in the 2023–24 RSV season. This study examined the association between caregiver vaccination (seas...

  • Article
  • Open Access
640 Views
18 Pages

Exploratory Evaluation of Peptide-Based Immunization Targeting Fusion Glycoprotein-Derived Epitopes of Nipah Virus in Murine Model

  • Seo Young Moon,
  • Rochelle A. Flores,
  • Eun Bee Choi,
  • Seungyeon Kim,
  • Hyunjin Je,
  • Eun Young Jang,
  • Heeji Lim,
  • Yoo-Kyoung Lee,
  • In-Ohk Ouh and
  • Woo H. Kim

13 January 2026

Background: Nipah virus (NiV), a zoonotic paramyxovirus with high case fatality and pandemic potential, remains without a licensed vaccine for humans to date. Although there has been progress in vaccine development, it remains limited, and peptide va...

  • Editorial
  • Open Access
357 Views
6 Pages

Myriad Pathways to Universality: How Widely Sourced Data, Use of Frameworks and Innovative Analytic Methods Help Tackle Immunization Inequality

  • Devaki Nambiar,
  • Ahmad Reza Hosseinpoor,
  • Nicole Bergen,
  • M. Carolina Danovaro-Holliday,
  • Ibrahim Dadari and
  • Hope L. Johnson

13 January 2026

Great strides have been made in the area of immunization over the past several decades [...]

  • Article
  • Open Access
364 Views
28 Pages

Efficacy of Plasmid DNA Delivery into Mice by Intradermal Injections Alone and Facilitated by Sonoporation or Electroporation

  • Daria Avdoshina,
  • Vladimir Valuev-Elliston,
  • Maria Belikova,
  • Alla Zhitkevich,
  • Anastasia Latanova,
  • Galina Frolova,
  • Oleg Latyshev,
  • Ilya Gordeychuk and
  • Ekaterina Bayurova

12 January 2026

Background/Objectives: A key disadvantage of DNA vaccines is ineffective uptake of plasmid DNA, resulting in low immunogenicity. A way to overcome it is forced DNA delivery, which requires specialized equipment and/or reagents. Effective delivery of...

  • Review
  • Open Access
504 Views
22 Pages

Plant Viral Vectors for Vaccine Development

  • Mehdi Shahgolzari,
  • Afagh Yavari,
  • Srividhya Venkataraman,
  • Mehrin Faija and
  • Kathleen Hefferon

12 January 2026

Plant viruses are useful tools for quickly and easily producing recombinant proteins in plants. Compared to systems that use genetically modified plants, viral vectors are easier to work with and can produce recombinant proteins faster and in larger...

  • Article
  • Open Access
515 Views
19 Pages

Self-Multimerization of mRNA LNP-Derived Antigen Improves Antibody Responses

  • Cody A. Despins,
  • James Round,
  • Lisa Dreolini,
  • Tracy S. Lee,
  • Scott D. Brown and
  • Robert A. Holt

12 January 2026

Background: mRNA LNP technology is now being widely applied as a highly effective vaccine platform. Antigen multimerization is a well-established approach to enhance the antibody titers and protective efficacy of several protein subunit vaccines. How...

  • Article
  • Open Access
594 Views
21 Pages

Beyond the Virological Benefits of the Herpes Zoster Vaccine in the Context of Primary Care

  • Carlo Fabris,
  • Lorena De Cecco Beolchi,
  • Lucia Casatta,
  • Stefano Celotto,
  • Marina Pellegrini,
  • Serafina Lovascio,
  • Katia Urli and
  • Pierluigi Toniutto

11 January 2026

Background/Objectives: Recently, the Herpes Zoster (HZ) vaccination has been introduced, alongside influenza and pneumococcal vaccination, at age 65. Factors influencing adherence to this vaccination and its clinical benefits are not completely under...

  • Article
  • Open Access
577 Views
17 Pages

11 January 2026

Background/Objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the global COVID-19 pandemic, which led to hundreds of millions of human infections and more than seven million deaths worldwide. Major variants of concern, pa...

  • Article
  • Open Access
477 Views
14 Pages

Donor Plasmid Optimization Enhances Expression of Feline Parvovirus VP2 Protein in the Baculovirus Expression Vector System

  • Ziyan Meng,
  • Zhen Sun,
  • Jing Li,
  • Wenjia Qiu,
  • Jiaqi Wei,
  • Ruitong Zhang,
  • Xiaoyu Ji,
  • Hongwei Zhu,
  • Jiayu Yu and
  • Xingxiao Zhang
  • + 4 authors

10 January 2026

Background: Feline panleukopenia virus (FPV) causes acute and frequently fatal disease in cats, underscoring the urgent need for safe, rapidly effective, and scalable vaccines. While virus-like particle (VLP) vaccines are inherently safe and immunoge...

  • Article
  • Open Access
485 Views
16 Pages

Maternal Immunization with VP8* mRNA Vaccine Yields Superior Passive Transfer of Rotavirus-Neutralizing Antibodies to Foals

  • Karin E. R. Borba,
  • Rebecca M. Legere,
  • Nathan M. Canaday,
  • Jill W. Skrobarczyk,
  • Zachary W. T. Arnold,
  • Elena Cotton-Betteridge,
  • Cristina Poveda,
  • Michael F. Criscitiello,
  • Angela I. Bordin and
  • Noah D. Cohen
  • + 2 authors

9 January 2026

Background: Despite the availability of a killed whole-virus (KV) vaccine, diarrhea caused by equine rotavirus group A (ERVA) remains a significant health concern for foals in the United States. The vaccine is administered to pregnant mares, with foa...

  • Article
  • Open Access
758 Views
12 Pages

Effectiveness of Follow-Up Mass Vaccination Campaigns Against Measles and Rubella to Mitigate Epidemics in West Africa (2024–2025): A Cross-Sectional Analysis of Surveillance and Coverage Data

  • Marcellin Mengouo Nimpa,
  • Ado Mpia Bwaka,
  • Felix Amate Elime,
  • Milse William Nzingou Mouhembe,
  • Adama Nanko Bagayoko,
  • Edouard Mbaya Munianji,
  • Christian Tague,
  • Joel Lamika Kalabudi and
  • Criss Koba Mjumbe

9 January 2026

Background/Objectives: Despite large-scale measles and rubella (MR) vaccination campaigns in West Africa, measles outbreaks persist, raising concerns about campaign effectiveness, coverage, and underlying determinants. This study assesses the impact...

  • Article
  • Open Access
630 Views
17 Pages

COVID-19 Vaccination Knowledge, Attitudes, Perception, and Practices Among Frontline Healthcare Workers in Tunisia, 2024

  • Fatma Ben Youssef,
  • Aicha Hechaichi,
  • Hajer Letaief,
  • Sonia Dhaouadi,
  • Amenallah Zouaiti,
  • Khouloud Talmoudi,
  • Sami Fitouri,
  • Ahlem Fourati,
  • Rim Mhadhbi and
  • Nissaf Bouafif ep Ben Alaya
  • + 7 authors

9 January 2026

Background/Objectives: Healthcare workers (HCW) in primary care settings play a significant role in recommending vaccines to patients. We aimed to describe COVID-19 vaccination knowledge, attitudes, perception, and practices (KAPP) of HCWs in Tunisia...

  • Article
  • Open Access
735 Views
21 Pages

Non-Vaccine Serotype Replacement and Subdominant Persistence of Vaccine Types in Nepalese Infants Following PCV10 Introduction

  • Fleurette Mbuyakala Domai,
  • Dhruba Shrestha,
  • Raj Kumar Shrestha,
  • Monika Thimi,
  • Desmond Opoku Ntiamoah,
  • Yumiko Hayashi,
  • Chris Smith,
  • Yoshinao Kubo,
  • Shunmay Yeung and
  • Bhim Gopal Dhoubhadel
  • + 3 authors

8 January 2026

Background: Streptococcus pneumoniae is a leading cause of child mortality in Nepal despite the introduction of the 10-valent pneumococcal conjugate vaccine (PCV10). Vaccine effectiveness is threatened by the emergence of non-vaccine serotypes (...

  • Systematic Review
  • Open Access
574 Views
23 Pages

8 January 2026

Background: Solid organ transplant recipients (SOTRs) are highly vulnerable to severe COVID-19 infection, yet initial vaccine trials provided limited data on efficacy and safety in this immunocompromised population. Heterogeneous seroconversion rates...

  • Article
  • Open Access
630 Views
19 Pages

Extended Heterosubtypic Neutralization and Preclinical Model In Vivo Protection from Clade 2.3.4.4b H5 Influenza Virus Infection by Broadly Neutralizing Antibodies

  • Valeria Caputo,
  • Martina Libera,
  • Yailin Campos Mota,
  • Kaito Nagashima,
  • Ana Maria Moreno Martin,
  • Claudia Maria Trombetta,
  • Francesca Dapporto,
  • Jarrod J. Mousa,
  • Emanuele Montomoli and
  • Roberta Antonia Diotti
  • + 1 author

8 January 2026

Background/Objective: The influenza virus remains one of the most prevalent respiratory pathogens, posing significant global health and economic challenges. According to the World Health Organization, the seasonal influenza virus infects up to 1 bill...

  • Article
  • Open Access
615 Views
10 Pages

Effectiveness of the Cell-Based Quadrivalent Influenza Vaccine (SKYCellflu® QIV) in Children and Adolescents: A Multicenter Test-Negative Case–Control Study in Korea

  • Yoonsun Yoon,
  • Hye Su Jeong,
  • Kyeongmin Oh,
  • Young June Choe,
  • Hyun Mi Kang,
  • Ji Young Park,
  • Hye Young Kim and
  • Yun-Kyung Kim

8 January 2026

Background: Children and adolescents are pivotal in the transmission of influenza, and vaccination remains the most effective preventive measure. Cell-based influenza vaccines offer advantages over traditional egg-based vaccines by reducing egg-adapt...

  • Article
  • Open Access
524 Views
17 Pages

Nanoparticle Vaccines Based on the Truncated VZV gE Elicit a Robust Immune Response in Mice

  • Tianxin Shi,
  • Hai Li,
  • Jiehui Wu,
  • Hongqiao Hu,
  • Jie Jiang,
  • Ruichen Wang,
  • Ziyi Li,
  • Qianqian Cui,
  • Shihong Fu and
  • Songtao Xu
  • + 4 authors

7 January 2026

Background: Herpes zoster (HZ), caused by the reactivation of varicella-zoster virus (VZV), primarily affects elderly populations worldwide. Although current recombinant HZ vaccines show strong immunogenicity, their high cost and potential side effec...

  • Article
  • Open Access
535 Views
24 Pages

Evaluating the Immunogenicity and Protective Efficacy of a Novel Vaccine Candidate Against Salmonella in Poultry

  • Roshen N. Neelawala,
  • Varsha Bommineni,
  • Chaitanya Gottapu,
  • Lekshmi K. Edison,
  • Krishni K. Gunathilaka,
  • Gary D. Butcher,
  • John F. Roberts and
  • Subhashinie Kariyawasam

7 January 2026

Background: Non-typhoidal Salmonella (NTS) is a major foodborne pathogen, with poultry products, especially eggs, being the primary source of human infections. Current serovar-specific poultry vaccines effectively reduce targeted Salmonella serovars...

  • Article
  • Open Access
584 Views
22 Pages

Alternative Childhood Vaccination Schedules in Israel: A Mixed-Methods Study on Prevalence, Patterns, and Public Health Implications

  • Efrat Sales,
  • Eliya Cohen,
  • Deena R. Zimmerman,
  • Nadav Davidovitch,
  • Alison McCallum and
  • Keren Dopelt

6 January 2026

Background/Objectives: Vaccination programs are highly effective public health interventions, yet parental hesitancy toward combination vaccines has led to growing demand for alternative vaccination schedules, defined in this study as parental reques...

  • Article
  • Open Access
557 Views
20 Pages

Preclinical Assessment of a New Virus-like Particle-Based Quadrivalent Human Papillomavirus Vaccine in Animal Models

  • Hajar Mohammadi Barzelighi,
  • Zahra Naderi Saffar,
  • Erfan Pakatchian,
  • Mohammad Taqavian,
  • Babak Javadimehr,
  • Mansooreh Safaeian,
  • Payam Abbaszadeh and
  • Hasan Jalili

5 January 2026

Background: A quadrivalent HPV vaccine (BPV) has been developed to prevent diseases caused by HPV types 6, 11, 16, and 18 for the first time in Iran. The BPV is composed of the papillomavirus major capsid protein L1, which serves as the primary targe...

  • Review
  • Open Access
1 Citations
1,237 Views
34 Pages

The Yellow Fever Vaccine Journey: Milestones and Future Directions

  • Shriyansh Srivastava,
  • Nandani Jayaswal,
  • Pranav Gupta,
  • Sathvik Belagodu Sridhar,
  • Pooja Jaiswal,
  • Mohd. Tariq,
  • G. S. N. Koteswara Rao,
  • Aroop Mohanty,
  • Sanjit Sah and
  • Alfonso J. Rodriguez-Morales
  • + 4 authors

5 January 2026

Yellow fever, a mosquito-borne viral hemorrhagic disease, remains a significant public health concern in endemic regions of Africa and South America. The development of the yellow fever vaccine marked a milestone in virology and immunization. In the...

  • Article
  • Open Access
480 Views
16 Pages

Broadening SARS-CoV-2 Immunity by Combining ORFV and Protein-Based Vaccines

  • Alena Reguzova,
  • Melanie Müller,
  • Madeleine Fandrich,
  • Alex Dulovic and
  • Ralf Amann

4 January 2026

Background: Emerging immune-evasive viral variants threaten the efficacy of current vaccines, underscoring the need for strategies that elicit broad and durable protection. Heterologous prime–boost regimens combining distinct vaccine platforms...

  • Article
  • Open Access
521 Views
22 Pages

Influenza Vaccine Immunogenicity in Hemodialysis Patients

  • Anna-Polina Shurygina,
  • Ekaterina Romanovskaya-Romanko,
  • Vera Krivitskaya,
  • Mariia Sergeeva,
  • Janna Buzitskaya,
  • Kirill Vasilyev,
  • Marina Shuklina,
  • Konstantin Vishnevskii,
  • Smotrov Dmitry and
  • Marina Stukova
  • + 2 authors

4 January 2026

Background: Patients with end-stage renal disease (ESRD) on hemodialysis are at increased risk for severe influenza, and underlying immune dysfunction may limit vaccine-induced protection. Methods: This observational open-label study evaluated immune...

  • Article
  • Open Access
488 Views
19 Pages

Immunotherapy of Canine Leishmaniasis by Vaccination with Singlet Oxygen-Inactivated Leishmania infantum

  • Laura Manna,
  • Raffaele Corso,
  • Bala K. Kolli,
  • Namhee Kim and
  • Kwang Poo Chang

4 January 2026

Background: Canine leishmaniasis is notoriously difficult to manage by chemotherapy alone, necessitating the consideration of supplemental or alternative treatment. Evidence is presented to support the feasibility of immunotherapy of diseased dogs th...

  • Article
  • Open Access
460 Views
10 Pages

The Reasons to Get Vaccinated: A Cross-Sectional Study on HPV Vaccination Adherence in a Northern Italian University

  • Pier Mario Perrone,
  • Riccardo Zanzi,
  • Elia Biganzoli,
  • Fabrizio Pregliasco and
  • Silvana Castaldi

4 January 2026

Background/Objectives: Human papillomavirus (HPV) represents a major public health challenge due to its high prevalence and the complications arising from infection. The aim of the study was to investigate the reasons for adherence to the HPV vaccina...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X